UPDATE 1-U.S. FDA warns Gilead on manufacturing plant

Sept. 30, 2010

Related

UK pharmaceuticals exempt from tariffs in US drug pricing agreement

UK pharmaceuticals exempt from tariffs in US drug pricing agreement

Agilent’s integration of recently acquired Biovectra remains a work in progress

Agilent’s integration of recently acquired Biovectra remains a work in progress

2026 Manufacturing Pharma Trends for Life Sciences

Sponsored

2026 Manufacturing Pharma Trends for Life Sciences

2026 AI Trends in Life Sciences

Sponsored

2026 AI Trends in Life Sciences

Trending

Charles River to close cell therapy CDMO site in Maryland acquired in 2021

Analysis of FDA drug approvals indicates favorable longer-term trend for CDMOs

Eurofins continues to make progress in leasing less, owning more strategic sites

Sponsored Picks

Sponsored

2026 Manufacturing Pharma Trends for Life Sciences

Sponsored

2026 AI Trends in Life Sciences

Sponsored

2026 Manufacturing Medical Device Trends for Life Sciences